ZA872120B - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- ZA872120B ZA872120B ZA872120A ZA872120A ZA872120B ZA 872120 B ZA872120 B ZA 872120B ZA 872120 A ZA872120 A ZA 872120A ZA 872120 A ZA872120 A ZA 872120A ZA 872120 B ZA872120 B ZA 872120B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- treatment
- infections
- pharmaceutical composition
- pessaries
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868607159A GB8607159D0 (en) | 1986-03-22 | 1986-03-22 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA872120B true ZA872120B (en) | 1987-10-28 |
Family
ID=10595080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA872120A ZA872120B (en) | 1986-03-22 | 1987-03-23 | Pharmaceutical composition |
Country Status (10)
Country | Link |
---|---|
US (1) | US4803066A (de) |
EP (1) | EP0241175B1 (de) |
JP (1) | JPS62252725A (de) |
AT (1) | ATE59297T1 (de) |
AU (1) | AU590060B2 (de) |
CA (1) | CA1280366C (de) |
DE (1) | DE3767003D1 (de) |
ES (1) | ES2038659T3 (de) |
GB (1) | GB8607159D0 (de) |
ZA (1) | ZA872120B (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266329A (en) * | 1985-10-31 | 1993-11-30 | Kv Pharmaceutical Company | Vaginal delivery system |
US4837378A (en) * | 1986-01-15 | 1989-06-06 | Curatek Pharmaceuticals, Inc. | Topical metronidazole formulations and therapeutic uses thereof |
JPH0818983B2 (ja) * | 1987-12-08 | 1996-02-28 | 塩野義製薬株式会社 | 水虫治療剤 |
US5002938A (en) * | 1988-03-21 | 1991-03-26 | Bristol-Myers Squibb Company | Antifungal gel formulations |
US5110809A (en) * | 1988-03-21 | 1992-05-05 | Bristol-Myers Squibb Company | Antifungal gel formulations |
CA1337279C (en) * | 1989-06-06 | 1995-10-10 | Robert J. Borgman | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
ZA939117B (en) * | 1992-12-04 | 1994-08-05 | Susanna Elizabeth Chalmers | Pharmaceutical product |
US5370876A (en) * | 1993-01-08 | 1994-12-06 | Microbarriers | Antimicrobial protective skin composition and method for protecting skin from body fluids |
US6709681B2 (en) * | 1995-02-17 | 2004-03-23 | Aberdeen University | Acidified nitrite as an antimicrobial agent |
HU215443B (hu) * | 1994-07-25 | 1999-04-28 | Márton Milánkovits | Többféle hatóanyagot tartalmazó gyógyszerkészítmények, főként hüvelykúp, baktericid, fungicid, protozoa- és vírusellenes kombinált hatással |
US6060604A (en) * | 1995-03-31 | 2000-05-09 | Florida State University | Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
WO1998051273A1 (en) | 1997-05-12 | 1998-11-19 | Sage Pharmaceuticals, Inc. | Topical spray for burn treatment and anti-infection |
US6224896B1 (en) | 1997-07-28 | 2001-05-01 | Curlor Healthcare Technologies, Llc | Composition and process for the treatment of epidermal traumas such as decubitus ulcers |
US20030147925A1 (en) * | 1998-09-11 | 2003-08-07 | Samuel P. Sawan | Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same |
US6582683B2 (en) | 2000-01-04 | 2003-06-24 | Skinvisible Pharmaceuticals, Inc. | Dermal barrier composition |
US7137968B1 (en) * | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
EP1267795A1 (de) * | 2000-03-30 | 2003-01-02 | Brennen Medical Inc. | Antimikrobielle und immunstimulierende zusammensetzung |
US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
US6989157B2 (en) * | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
US7427416B2 (en) * | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
US7255881B2 (en) * | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
US20030180379A1 (en) * | 2000-07-27 | 2003-09-25 | Burrell Robert E. | Solutions and aerosols of metal-containing compounds |
US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
US20030206966A1 (en) * | 2000-07-27 | 2003-11-06 | Burrell Robert E. | Methods of inducing apoptosis and modulating metalloproteinases |
US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
US20040191329A1 (en) * | 2000-07-27 | 2004-09-30 | Burrell Robert E. | Compositions and methods of metal-containing materials |
US20030185901A1 (en) | 2000-07-27 | 2003-10-02 | Burrell Robert E. | Methods of treating conditions with a metal-containing material |
WO2002009729A2 (en) | 2000-07-27 | 2002-02-07 | Nucryst Pharmaceuticals Corp. | Treatment of hyperproliferative skin disorders and diseases |
US6399092B1 (en) | 2000-12-27 | 2002-06-04 | Healthpoint, Ltd. | Anhydrous, hydrophilic absorbent wound dressing (tube) with antimicrobials or other pharmaceutically active agents |
WO2002085385A2 (en) | 2001-04-23 | 2002-10-31 | Nucryst Pharmaceuticals Corp. | Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa |
US6756059B2 (en) * | 2001-08-20 | 2004-06-29 | Skinvisible Pharmaceuticals, Inc. | Topical composition, topical composition precursor, and methods for manufacturing and using |
US7201925B2 (en) * | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
CA2500829A1 (en) * | 2002-10-22 | 2004-05-06 | Nucryst Pharmaceuticals Corp. | Prophylactic treatment methods |
US20040126339A1 (en) * | 2002-12-31 | 2004-07-01 | Roszell James A. | Sunscreen composition and methods for manufacturing and using a sunscreen composition |
BRPI0414500A (pt) * | 2003-09-19 | 2006-11-07 | Drugtech Corp | formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais |
US20060140990A1 (en) * | 2003-09-19 | 2006-06-29 | Drugtech Corporation | Composition for topical treatment of mixed vaginal infections |
US20050214364A1 (en) * | 2004-03-23 | 2005-09-29 | Hutman Herbert W | Products and methods for treating vaginal infections |
CN101170993A (zh) * | 2005-05-09 | 2008-04-30 | 药物技术公司 | 修饰释放的药物组合物 |
US8481049B2 (en) * | 2005-05-27 | 2013-07-09 | Bharat Biotech International Limited | Methods for treating a wound using epidermal growth factor formulation |
EA200870153A1 (ru) * | 2006-01-05 | 2008-12-30 | Драгтек Корпорейшн | Композиция и способ ее использования |
KR20080083190A (ko) * | 2006-01-05 | 2008-09-16 | 드러그테크 코포레이션 | 외음질 표면에 생체접착을 위한 약물 전달 시스템 |
WO2008005705A2 (en) * | 2006-06-30 | 2008-01-10 | Nucryst Pharmaceuticals Corp. | Metal-containing formulations and methods of use |
WO2008066618A2 (en) * | 2006-10-20 | 2008-06-05 | Skinvisible Pharmaceuticals, Inc. | Antifungal composition and methods for using |
US8128913B1 (en) | 2007-12-06 | 2012-03-06 | Skinvisible Pharmaceuticals, Inc. | Sunscreen composition with enhanced UV-A absorber stability and methods |
US8865227B2 (en) * | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
US8299122B2 (en) * | 2008-04-14 | 2012-10-30 | Skinvisible Pharmaceuticals, Inc. | Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition |
FR2978664B1 (fr) | 2011-08-04 | 2014-01-10 | Petcare Innovation | Composition antiseptique |
CA2959414C (en) | 2014-09-05 | 2023-03-14 | Symbiomix Therapeutics, Llc | Secnidazole for use in the treatment of bacterial vaginosis |
PL411078A1 (pl) * | 2015-01-27 | 2016-08-01 | Uniwersytet Medyczny w Łodzi | Związek kompleksowy srebra, sposób wytwarzania związku kompleksowego oraz zastosowanie związku kompleksowego |
CA3074150A1 (en) | 2020-02-18 | 2021-08-18 | Ovation Science, Inc. | Composition and method for transdermal delivery of cannabidiol (cbd) and delta9-tetrahydrocannabinol (thc) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2319852A1 (de) * | 1972-04-21 | 1973-10-25 | Biological Concepts Inc | Verfahren zur herstellung einer zur aufnahme von arzneimitteln geeigneten, saugfaehigen fasermasse aus protein, insbesondere aus kollagen |
FR2440371A1 (fr) * | 1978-10-31 | 1980-05-30 | Fisons Ltd | Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer |
DE3280021D1 (en) * | 1981-06-12 | 1989-12-21 | Nat Res Dev | Hydrogels |
FR2558058B1 (fr) * | 1984-01-18 | 1987-03-20 | Pf Medicament | Compositions dermatologiques a usage topique externe, a base de metronidazole utiles pour le traitement de l'acne |
US4636520A (en) * | 1984-07-16 | 1987-01-13 | Fujisawa Pharmaceutical Co., Ltd. | Antifungal composition employing pyrrolnitrin in combination with an imidazole compound |
-
1986
- 1986-03-22 GB GB868607159A patent/GB8607159D0/en active Pending
-
1987
- 1987-03-19 US US07/027,861 patent/US4803066A/en not_active Expired - Fee Related
- 1987-03-23 CA CA000532694A patent/CA1280366C/en not_active Expired - Lifetime
- 1987-03-23 AU AU70543/87A patent/AU590060B2/en not_active Ceased
- 1987-03-23 AT AT87302490T patent/ATE59297T1/de not_active IP Right Cessation
- 1987-03-23 ZA ZA872120A patent/ZA872120B/xx unknown
- 1987-03-23 ES ES198787302490T patent/ES2038659T3/es not_active Expired - Lifetime
- 1987-03-23 JP JP62070160A patent/JPS62252725A/ja active Pending
- 1987-03-23 DE DE8787302490T patent/DE3767003D1/de not_active Expired - Lifetime
- 1987-03-23 EP EP87302490A patent/EP0241175B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU7054387A (en) | 1987-09-24 |
EP0241175A1 (de) | 1987-10-14 |
ES2038659T3 (es) | 1993-08-01 |
CA1280366C (en) | 1991-02-19 |
ATE59297T1 (de) | 1991-01-15 |
EP0241175B1 (de) | 1990-12-27 |
GB8607159D0 (en) | 1986-04-30 |
DE3767003D1 (de) | 1991-02-07 |
AU590060B2 (en) | 1989-10-26 |
JPS62252725A (ja) | 1987-11-04 |
US4803066A (en) | 1989-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA872120B (en) | Pharmaceutical composition | |
CA2148928A1 (en) | Pharmacologically active pyridine derivatives and processes for the preparation thereof | |
AU6194694A (en) | Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
AU2745700A (en) | A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same | |
AU563748B2 (en) | Quinolone carboxylic acids | |
MY102101A (en) | Pharmaceutical gel composition | |
AU5669198A (en) | Cyclosporin derivative, its preparation and pharmaceutical compositions containing same | |
CA2211389A1 (en) | Novel pharmaceutical combination | |
CA2328368A1 (en) | Anti-inflammatory agents | |
WO1989006649A3 (en) | Antibacterial agents | |
ES2004395A6 (es) | Procedimiento de obtencion de un sistema de vehiculo disolvente de doble fase, para compuestos farmaceuticamente activos. | |
IE863104L (en) | Quinolone derivatives | |
AU531878B2 (en) | Medicated animal feed based on liver meal | |
AU1890295A (en) | Piperidines and pyrrolidines | |
EP0249194A3 (de) | Topische Prostaglandinzusammensetzungen | |
AR003176A1 (es) | Una composicion farmaceutica para inhibir el crecimiento de cancer | |
AU7742594A (en) | Novel compositions | |
AU2861389A (en) | Disubstituted pyridines | |
ZA979647B (en) | Heterocyclic compounds, compositions and uses. | |
AU3435189A (en) | Topically applied gold organic complex | |
EP0370300A3 (de) | Cyclopropyl-Substituierte Azolylmethylcarbinole, Verfarhren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
AU6608994A (en) | Compositions for the treatment of inflammatory proliferative skin disease and their use | |
AU559768B2 (en) | Aluminium or zinc panthenolate and their use for treating wounds | |
IE811594L (en) | Pharmaceutical formulations | |
ZA979650B (en) | Heterocyclic compounds, compositions and uses. |